Patients With Genetic Heart Disease and COVID-19: A Cardiac Society of Australia and New Zealand (CSANZ) Consensus Statement.
Full text not available from this repository.| Item Type: | Article |
|---|---|
| Status: | Published |
| Official URL: | https://doi.org/10.1016/j.hlc.2020.04.006 |
| Journal or Publication Title: | Heart, Lung and Circulation |
| Volume: | 29 |
| Number: | 7 |
| Page Range: | e85-e87 |
| Date: | 2020 |
| Divisions: | Cardio Genomics Molecular Cardiology |
| Depositing User: | General Admin |
| Identification Number: | 10.1016/j.hlc.2020.04.006 |
| ISSN: | 14439506 |
| Date Deposited: | 04 Jan 2021 03:33 |
| Abstract: | In the context of the current global COVID-19 pandemic, this Consensus Statement provides current recommendations for patients with, or at risk of developing, genetic heart disease, and for their health care management and service provision in Australia and New Zealand. Apart from general recommendations, there are specific recommendations for the following conditions: cardiomyopathy, Brugada syndrome (including in children), long QT syndrome (LQTS) and catecholaminergic polymorphic ventricular tachycardia (CPVT). Other recommendations are relevant to patient self-care and primary health care. |
| Creators: | Creators Email Gray, Belinda UNSPECIFIED Semsarian, Christopher UNSPECIFIED Fatkin, Diane UNSPECIFIED Ingles, Jodie UNSPECIFIED Atherton, John J. UNSPECIFIED Davis, Andrew M. UNSPECIFIED Sanders, Prashanthan UNSPECIFIED Pachter, Nicholas UNSPECIFIED Skinner, Jonathan R. UNSPECIFIED Stiles, Martin K. UNSPECIFIED |
| Last Modified: | 04 Jan 2021 03:33 |
| URI: | https://eprints.centenary.org.au/id/eprint/738 |
Actions (login required)
 |
View Item |
